Two Sigma Investments
LSTA icon

Two Sigma Investments’s Lisata Therapeutics LSTA Stock Holding History

Two Sigma Investments’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,289
Closed -$68K – 2761
2022
Q1 		$68K Sell
6,289
-4,387
-41% -$50.2K ﹤0.01% 2466
2021
Q4 		$135K Buy
+10,676
New +$165K ﹤0.01% 4005

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Two Sigma Investments's LSTA Position: Q2 2022 in Review

Two Sigma Investments sold out of Lisata Therapeutics (LSTA) in Q2 2022, closing a stake of 6,289 shares — an estimated $68K sold.

Two Sigma Investments first reported a position in LSTA in Q4 2021 and held it in 2 quarters. The position peaked at $135K in Q4 2021. 34 funds tracked by Wall St. Rank hold LSTA as of Q2 2022.

  • Two Sigma Investments reported no remaining Lisata Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Investments sold 6,289 Lisata Therapeutics shares in Q2 2022, an estimated $68K.
  • Two Sigma Investments first reported a position in Lisata Therapeutics in Q4 2021 and held it in 2 quarters.
  • Two Sigma Investments's Lisata Therapeutics position peaked at $135K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2022.

Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.